Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04188834 · ClinicalTrials.gov registry record · NA

Effects of Sensory Flicker and Electrical Flicker Stimulation

A NA study of Brain Diseases, sponsored by Emory University.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT04188834 is a NA study of Brain Diseases that has completed, run by Emory University. The registered enrollment target is 23 participants, below the 6,016-participant average among 12 other Brain Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04188834, a NA study of Brain Diseases, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

The study will evaluate whether sensory flicker can modulate neural activity of deep brain regions in humans, and whether it can have relevant effects on behavior. Moreover, it will compare those effects to the gold-standard method of modulating brain circuits, direct electrical stimulation of the brain (the same mechanism as deep brain stimulation), using a powerful within-subjects design.

Conditions Studied

Brain Diseases

Interventions

  • DEVICE Customized version of DAVID device
  • DEVICE Blackrock CereStim

Study Locations (1)

Georgia

  • Emory University Hospital - Atlanta

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2020-01-10
Est. Completion 2022-11-22
Phase NA

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04188834

The ClinicalTrials.gov registry entry for NCT04188834 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,016-participant average among 12 other Brain Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Brain Diseases appearing as the primary indexed condition, and to 2 interventions - of which Customized version of DAVID device is the first listed.

NCT04188834 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT04188834 about?

NCT04188834 is a clinical study titled "Effects of Sensory Flicker and Electrical Flicker Stimulation". The study will evaluate whether sensory flicker can modulate neural activity of deep brain regions in humans, and whether it can have relevant effects on behavior. Moreover, it will compare those effects to the gold-standard method of modulating brain circuits, direct electrical stimulation of the b...

What is the current status of trial NCT04188834?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2020-01-10. Estimated completion is 2022-11-22.

What conditions does trial NCT04188834 study?

This clinical trial studies the following conditions: Brain Diseases.

What interventions are being tested in trial NCT04188834?

The interventions under investigation include: Customized version of DAVID device (DEVICE), Blackrock CereStim (DEVICE).

Who is sponsoring clinical trial NCT04188834?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04188834 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Brain Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Brain Diseases

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.